Multiple lipid-lowering treatment in pediatric patients with hyperlipidemia

Medicinal Chemistry

Volumn 8, Issue 6, 2012, Pages 1171-1181

  Stefanutti, Claudia ^a   Mazza, Fabio ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Atorvastatin; Cardiovascular risk; Dietary and drug treatment in childhood; Dyslipidemia in children; Ezetimibe; Glucomannan; Overweight in children; Polygenic and monogenic dyslipidemia

Indexed keywords

ATORVASTATIN; CHOLESTEROL; EZETIMIBE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MANNAN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; BODY WEIGHT; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; DIET; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD;

ADOLESCENT; ATHEROSCLEROSIS; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; MALE; RETROSPECTIVE STUDIES;

EID: 84868033296     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/1573406411208061171     Document Type: Article

References (34)

1. Stephen, R.; Frank, R. G.; and the Committee on Nutrition; Lipid screening and cardiovascular health in childhood. Pediatrics, 2008, 122, 198-208.
2. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults: executive summary of the third report of the National Cholesterol Education Program (NCEP)Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA, 2001, 285, 2486-2497.
3. Kavey, R.E.; Allada, V.; Daniels, S.R. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research-endorsed by the American Academy of Pediatrics. Circulation, 2006, 114, 2710-2738.
4. Gidding, S.S.; Dennison, B.A.; Birch, L.L. Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association. Circulation, 2005, 112, 2061-2075.
5. Lichtenstein, AH.; Appel, L.J.; Brands, M.; Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation, 2006, 114, 82-96.
6. Caldwell, P.H.Y.; Murphy, S.B.; Butow, P.N.; Craig, J.C. Clinical trials in children. Lancet, 2004, 364, 803-811.
7. Sammons, H.M.; Choonara, I. Clinical trials of medication in children, 1996-2002. Eur. J. Clin. Pharmacol., 2005, 61, 165-167.
8. Carmouze, G. Guidance for industry: how to comply with the Pediatric Research Equity act Draft, FDA - Guidance for Industry: Rockville 2005.
9. European Parliament. Report on the proposal for a regulation of the European Parliament and of the Council on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/83/EC and Regulation (EC) No 726/2004. (COM(2004)0599 - C6-0159/2004-2004/0217(COD)), Strasbourg 2005.
10. Commission of the European Communities. Regulation (EC) No 1901/2006 on medicinal products for paediatric use and amending Regulation (EC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004. Official Journal of the European Communities 2006.
11. Permanand, G.; Mossialos, E.; McKee, http://www.fetalneonatal.com/ content/92/9/808.full - aff-2#aff-2 M. The EU's new paediatric medicines legislation: serving children's needs? Arch. Dis. Child., 2007, 92, 808-811.
12. Gidding, S.S.; Dennison, BA.; Birch, L.L.; Daniels, S.R.; Gillman, M.W.; Lichtenstein, A.H.; Rattay, K.T.; Steinberger, J.; Stettler, N.; Van Horn, L; American Heart Association. Dietary Recommendations for Children and Adolescents: A Guide for Practitioners. Pediatrics, 2006, 117, 544-559.
13. Jenssen, B.P.; Jacobson, M.S. Screening adolescents for lipid disorders: what is the best approach? Adolesc. Med. State. Art Rev., 2008, 19, 507-520.
14. Zappalla, F.R.; Gidding, S.S. Lipid management in children. Endocrino. l Metab. Clin. North. Am., 2009, 38, 171-183.
15. Ford, E.S.; Li, C.; Zhao, G.; Mokdad, A.H. Concentrations of lowdensity lipoprotein cholesterol and total cholesterol among children and adolescents in the United States. Circulation, 2009, 119, 1108-1115.
16. Anderson, K.M.; Wilson, P.W.F.; Odell, P.M.; Kannel, W.B. An updated coronary risk profile. A statement for health professionals. Circulation, 1991, 83, 356-362.
17. American Academy of Pediatrics: Cardiovascular Risk Reduction in High-Risk Pediatric Populations. Pediatrics, 2007, 119, 618-621.
18. McCrindle, B.W.; Urbina, E.M.; Dennison, B.A. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council on Cardiovascular Disease in the Young, Council on Cardiovascular Nursing. Circulation, 2007, 115, 1948-1967.
19. Lavie, C.J.; Milani, R.V.; Ventura, H.O. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J. Am. Coll. Cardiol., 2009, 53, 1925-1932.
20. Lichtenstein, A.H.; Deckelbaum, R.J. American Heart Association Science Advisory. Stanol/sterol ester-containing foods and blood cholesterol levels: a statement for healthcare professionals from the Nutrition Committee of the Council on Nutrition, Physical Activity, and Metabolism of the American Heart Association. Circulation, 2001, 103, 1177-1179.
21. Varady, K.A.; Houweling, A.H.; Jones, P.J. Effect of plant sterols and exercise training on cholesterol absorption and synthesis in previously sedentary hypercholesterolemic subjects. Transl. Res., 2007, 149, 22-30.
22. De Jongh, S.; Vissers, M.N.; Rol, P.; Bakker, H.D.; Kastelein, J.J.P. Plant sterols lower LDL cholesterol without improving endothelial function in prepubertal children with familial hypercholesterolaemia. J. Inherit. Metab. Dis., 2003, 26, 343-352.
23. Vido, L.; Facchin, P.; Antonello, I. Childhood obesity treatment: double blinded trial on dietary fibres (glucomannan) versus placebo. Pediatr. Padol., 1993, 28, 133-136.
24. Martino, F.; Martino, E.; Morrone, F.; Carnevali, E. Effect of dietary supplementation with glucomannan on plasma total cholesterol and low density lipoprotein cholesterol in hypercholesterolemic children. Nutr. Metab. Cardiovasc. Dis., 2005, 15, 174-180.
25. Sood, N.; Baker, W.L.; Coleman, C.I. Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis. Am. J. Clin. Nutr., 2008, 88, 1167-1175.
26. Sutcliffe, A.G.; Wong, I.C.K. Rational prescribing for children. BMJ, 2006, 332, 1464-1465.
27. Avis, H.J.; Vissers, M.N.; Wijburg, F.A.; Kastelein, J.J.; Hutten, B.A. The use of lipid-lowering drug therapy in children and adolescents. Curr. Opin. Investig. Drugs., 2009, 10, 224-231.
28. McCrindle, B.W.; Heldon, E.; Cullen-Dean, G.; Conner, W.T. A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia. Pediatr. Res., 2002, 51, 715-721.
29. Iughetti, L.; Predieri, B.; Balli, F.; Calandra, S. Rational approach to the treatment for heterozygous familial hypercholesterolemia in childhood and adolescence: a review. J. Endocrino.l Invest., 2007, 30, 700-719.
30. Clauss, S.; Wai, K.; Kavey, R. W. Ezetimibe treatment of pediatric patients with hypercholesterolemia. J. Pediatr., 2009, 154, 869-872.
31. Wiegman, A.; Hutten, B.A.; De Groot, E. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA, 2004, 292, 331-337.
32. De Jongh, S.; Ose, L., Szamosi, T. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized, double-blind, placebo-controlled trial with simvastatin. Circulation, 2002, 106, 2231-2237.
33. Stefanutti, C.; Lucani, G.; Vivenzio, A.; Di Giacomo, S. Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood. Drugs Exp. Clin. Res., 1999, 25, 23-28.
34. Mc Crindle, B.W.; Ose, L.; Marais, A.D. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo- controlled trial. J. Pediatr., 2003, 143, 74-80.